Association of angiotensin-converting enzyme gene promoter single nucleotide polymorphisms and haplotype with major depression in a northeastern Thai population

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 10, Issue 3, 2009, Pages 179-184

  Angunsri, Rudee ^a   Sritharathikhun, Thapanut ^b   Suttirat, Sarawut ^c   Tencomnao, Tewin ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Loei Rajanagarindra Psychiatric Hospital   (Thailand)

^c HUACHIEW CHALERMPRAKIET UNIVERSITY   (Thailand)

Author keywords

Angiotensin converting enzyme; Association study; Genetic polymorphism; Major depression; Thai population

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; POPULATION RESEARCH; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; THAILAND;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; THAILAND;

EID: 69849090279     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.1177/1470320309344151     Document Type: Article

References (33)

1. Lopez AD, Mathers CD, Ezzati M., Jamison DT, Murray CJ Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747-57.
2. Murray CJ, Lopez AD Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-42.
3. Sullivan PF, Neale MC, Kendler KS Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry 2000;157:1552-62.
4. Levinson DF The genetics of depression: A review. Biol Psychiatry 2006;60:84-92.
5. Price RA, Kidd KK, Weissman MM Early onset (under age 30 years) and panic disorder as markers for etiologic homogeneity in major depression. Arch Gen Psychiatry 1987;44:434-40.
6. Moldin SO, Reich T., Rice JP Current perspectives on the genetics of unipolar depression. Behav Genet 1991;21:211-42.
7. Marazita ML, Neiswanger K., Cooper M. et al. Genetic segregation analysis of early-onset recurrent unipolar depression. Am J Hum Genet 1997;61:1370-8.
8. Kendler KS, Gardner CO, Prescott CA Toward a comprehensive developmental model for major depression in women. Am J Psychiatry 2002;159:1133-45.
9. Kendler KS, Kuhn JW, Prescott CA Childhood sexual abuse, stressful life events and risk for major depression in women. Psychol Med 2004;34:1475-82.
10. Jefferson JW Lamotrigine in psychiatry: Pharmacology and therapeutics. CNS Spectr 2005;10:224-32.
11. Zubenko GS, Nixon RA Mood-elevating effect of captopril in depressed patients. Am J Psychiatry 1984;141:110-11.
12. Vuckovic A., Cohen BM, Zubenko GS The use of captopril in treatment-resistant depression: An open trial. J Clin Psychopharmacol 1991;11:395-6.
13. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 1999;33:181-214.
14. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000;23:477-501.
15. Stokes PE, Stoll PM, Koslow SH et al. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. Arch Gen Psychiatry 1984;41:257-67.
16. Owens MJ, Nemeroff CB The role of corticotropin releasing factor in the pathophysiology of affective and anxiety disorders: Laboratory and clinical studies. Ciba Found Symp 1993;172:296-308.
17. Nemeroff CB The corticotropin-releasing factor (CRF) hypothesis of depression: New findings and new directions. Mol Psychiatry 1996;1:336-42.
18. Van Den Eede F., Van den Bossche B., Hulstijn W., Sabbe BG, Cosyns P., Claes SJ Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder. J Affect Disord 2006;93:259-63.
19. Hubert C., Houot AM, Corvol P., Soubrier F. Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 1991;266:15377-83.
20. Sayed-Tabatabaei FA, Oostra BA, Isaacs A., van Duijn CM, Witteman JC ACE polymorphisms. Circ Res 2006;98:1123-33.
21. Villard E., Tiret L., Visvikis S., Rakotovao R., Cambien F., Soubrier F. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 1996;58:1268-78.
22. Foy CA, Rice GI, Ossei-Gerning N., Mansfield MW, Grant PJ Angiotensin-converting enzyme (ACE) gene polymorphisms in patients characterised by coronary angiography. Hum Genet 1997;100:420-5.
23. Baghai TC, Binder EB, Schule C. et al. Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry 2006;11:1003-15.
24. Wang HK, Fung HC, Hsu WC et al. Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia. J Neural Transm 2006;113:1499-509.
25. Katzov H., Bennet AM, Kehoe P. et al. A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity. Hum Mol Genet 2004;13:2647-57.
26. Hsieh YY, Chang CC, Tsai FJ, Hsu CM, Lin CC, Tsai CH Angiotensin I converting enzyme ACE 2350*G and ACE -240*T-related genotypes and alleles are associated with higher susceptibility to endometriosis. Mol Hum Reprod 2004;11:11-14.
27. Lewontin RC On measures of gametic disequilibrium. Genetics 1988;120:849-52.
28. Weale ME, Depondt C., Macdonald SJ et al. Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: Implications for linkage-disequilibrium gene mapping. Am J Hum Genet 2003;73:551-65.
29. Johnson AD, Gong Y., Wang D. et al. Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertension. Clin Pharmacol Ther 2009;85:36-44.
30. Gard PR, Mandy A., Sutcliffe MA Evidence of a possible role of altered angiotensin function in the treatment, but not etiology, of depression. Biol Psychiatry 1999;45:1030-4.
31. Tencomnao T., Boonmalert R. Misgenotyping of dopamine receptor D1 gene -48A/G polymorphism. Am J Med Genet B Neuropsychiatr Genet 2009;150B:447-9.
32. Gormley K., Bevan S., Markus HS Polymorphisms in genes of the renin-angiotensin system and cerebral small vessel disease. Cerebrovasc Dis 2007;23:148-55.
33. Rebaï M., Kharrat N., Ayadi I., Rebaï A. Haplotype structure of five SNPs within the ACE gene in the Tunisian population. Ann Hum Biol 2006;33:319-29.